COVID cases decline as Canada braces for flu season pressure on hospitals

The numbers are finally moving in the right direction. For the first time since mid-July, Canada's COVID-19 reproductive rate has dipped below one—the epidemiological threshold that signals new infections are beginning to shrink rather than multiply. Last week, the Public Health Agency of Canada recorded an average of roughly 3,160 new cases daily, a fifteen percent drop from the previous week's 3,745. After months of climbing case counts, the curve is bending downward at last.

Yet Dr. Theresa Tam, Canada's chief public health officer, is not celebrating. At a Friday press conference, she offered a warning wrapped in cautious language: the approaching flu season could collide with whatever remains of the COVID wave, and the collision could break the health care system. Thousands of Canadians are still hospitalized with COVID-19. Hospitals are already strained. The timing, she suggested, could not be worse.

The threat is real because of what did not happen last year. When Canada imposed strict public health measures in the fall and winter of 2020, those measures did more than slow COVID-19. They nearly eliminated the flu. Last season was, by Tam's account, virtually non-existent for influenza. That sounds like a victory—and it was—but it created a vulnerability. A population that did not encounter the flu virus last year has not built immunity to it. The virus itself, dormant in the background, has had a year to drift and mutate. Now, with restrictions lighter than they were and people moving more freely, the conditions are set for a resurgence.

"Even before COVID, there are some very, very severe influenza seasons where you are already going to get the emergency rooms crowded and your hospitals at overcapacity," Tam said. "So this is definitely not the year to have influenza wreak havoc." The scenario she was describing—a fourth wave of COVID overlapping with a hard flu season—would stretch hospital capacity beyond what it can bear.

Tam's message to Canadians was direct: get the flu shot. Continue washing your hands. Stay home when you are sick. These are not new instructions, but the stakes have shifted. The flu vaccine, she emphasized, is more important now than it has been in years. It is the single most effective tool available to prevent the one crisis that could tip the system into genuine failure.

There is one more complication on the horizon. Pfizer and BioNTech have submitted preliminary trial data for a COVID-19 vaccine designed for children under twelve, with a formal authorization request expected soon. But Tam offered a note of caution about what approval would actually mean on the ground. The doses Canada currently has in stock are formulated for adults. Children under twelve will likely need a lower dose. While it is theoretically possible to extract smaller doses from existing vials using different needles, Tam warned that doing so risks compromising the vaccine's effectiveness. "You can't just dilute that vial," she said, "because that might actually change some aspect of how the formulation might work." If a pediatric vaccine is approved, Canada may need to wait for specially formulated doses to arrive before vaccinating children—a delay that could matter as winter approaches.